GILD vs. ABBV
GILD (Gilead Sciences, Inc.) and ABBV (AbbVie Inc.) are both stocks. Both operate in the Drug Manufacturers - General industry within the Healthcare sector. Over the past 10 years, GILD returned 9.13%/yr vs 18.64%/yr for ABBV. Their 0.42 correlation means their historical movements had little consistent relationship.
Performance
GILD vs. ABBV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, GILD achieves a 11.55% return, which is significantly higher than ABBV's 9.22% return. Over the past 10 years, GILD has underperformed ABBV with an annualized return of 9.13%, while ABBV has yielded a comparatively higher 18.64% annualized return.
GILD
- 1D
- 3.13%
- 1M
- 3.03%
- 6M
- -4.44%
- YTD
- 11.55%
- 1Y
- 21.19%
- 3Y*
- 23.80%
- 5Y*
- 18.56%
- 10Y*
- 9.13%
- ALL TIME*
- 18.64%
ABBV
- 1D
- -0.53%
- 1M
- -5.95%
- 6M
- 9.71%
- YTD
- 9.22%
- 1Y
- 27.47%
- 3Y*
- 22.33%
- 5Y*
- 20.54%
- 10Y*
- 18.64%
- ALL TIME*
- 20.08%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
ABBV AbbVie Inc. | $1.54B | $1.55B | $1.63B |
| $883.63M | $898.88M | $999.96M |
GILD vs. ABBV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
GILD Gilead Sciences, Inc. | 11.55% | 36.59% | 18.68% | -1.99% | 23.63% | 29.95% | -6.70% | 7.88% | -9.92% | 2.96% |
ABBV AbbVie Inc. | 9.22% | 33.08% | 18.86% | -0.23% | 24.01% | 32.43% | 27.72% | 1.47% | -0.96% | 60.07% |
Correlation
The correlation between GILD and ABBV is 0.38, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.38 |
Correlation (3Y) Balances recent behavior with more history. | 0.39 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.44 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.43 |
Correlation (All Time) Calculated using the full available price history since Jan 2, 2013 | 0.42 |
Fundamentals
GILD:
$167.92B
ABBV:
$430.74B
GILD:
$4.18
ABBV:
$3.57
GILD:
32.32
ABBV:
68.39
GILD:
5.56
ABBV:
6.71
GILD:
$30.46B
ABBV:
$64.39B
GILD:
$12.58B
ABBV:
$47.71B
GILD:
-$53.00M
ABBV:
$19.30B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GILD vs. ABBV — Risk / Return Rank
GILD
ABBV
GILD vs. ABBV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Gilead Sciences, Inc. (GILD) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GILD | ABBV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.27 | ||
| Sortino ratioReturn per unit of downside risk | -0.28 | ||
| Omega ratioGain probability vs. loss probability | 1.15 | 1.20 | -0.05 |
| Calmar ratioReturn relative to maximum drawdown | 0.99 | 1.59 | -0.61 |
| Martin ratioReturn relative to average drawdown | 2.23 | 3.51 | -1.29 |
Loading charts...
Drawdowns
GILD vs. ABBV - Drawdown Comparison
The maximum GILD drawdown since its inception was -70.83%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for GILD and ABBV.
Loading charts...
Drawdown Indicators
| GILD | ABBV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -70.83% | -45.09% | -25.74% |
Max Drawdown (1Y)Largest decline over 1 year | -21.59% | -17.32% | -4.27% |
Max Drawdown (3Y)Largest decline over 3 years | -26.59% | -20.74% | -5.85% |
Max Drawdown (5Y)Largest decline over 5 years | -26.59% | -21.92% | -4.67% |
Max Drawdown (10Y)Largest decline over 10 years | -30.47% | -45.09% | +14.62% |
Current DrawdownCurrent decline from peak | -12.12% | -7.41% | -4.71% |
Average DrawdownAverage peak-to-trough decline | -22.13% | -10.63% | -11.50% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.55% | 7.84% | +1.71% |
Volatility
GILD vs. ABBV - Volatility Comparison
Gilead Sciences, Inc. (GILD) has a higher volatility of 9.59% compared to AbbVie Inc. (ABBV) at 7.27%. This indicates that GILD's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GILD | ABBV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.59% | 7.27% | +2.32% |
Volatility (6M)Calculated over the trailing 6-month period | 19.45% | 19.67% | -0.22% |
Volatility (1Y)Calculated over the trailing 1-year period | 27.14% | 26.07% | +1.07% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 24.57% | 23.48% | +1.09% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.48% | 25.94% | -0.46% |
Dividends
GILD vs. ABBV - Dividend Comparison
GILD's dividend yield for the trailing twelve months is around 2.38%, less than ABBV's 2.80% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABBV AbbVie Inc. | 2.80% | 2.87% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% |
GILD Gilead Sciences, Inc. | 2.38% | 2.57% | 3.33% | 3.70% | 3.40% | 3.91% | 4.67% | 3.88% | 3.65% | 2.90% | 2.57% | 1.27% |
Financials
GILD vs. ABBV - Financials Comparison
This section allows you to compare key financial metrics between Gilead Sciences, Inc. and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
GILD and ABBV have a correlation of 0.38, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
GILD has higher volatility (9.59%) compared to ABBV (7.27%). In terms of maximum drawdown, GILD dropped -70.83% vs ABBV's -45.09%.
ABBV currently has the higher Sharpe Ratio (1.06 vs 0.78), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for GILD and ABBV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer